Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

15 trials with published results (22%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

4.3%

3 terminated out of 69 trials

Success Rate

91.4%

+4.9% vs benchmark

Late-Stage Pipeline

25%

17 trials in Phase 3/4

Results Transparency

47%

15 of 32 completed with results

Key Signals

15 with results91% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (34)
P 1 (2)
P 2 (1)
P 3 (7)
P 4 (10)

Trial Status

Completed32
Unknown12
Recruiting10
Active Not Recruiting6
Withdrawn3
Terminated3

Trial Success Rate

91.4%

Benchmark: 86.6%

Based on 32 completed trials

Clinical Trials (69)

Showing 20 of 20 trials
NCT05989581Phase 1RecruitingPrimary

Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project

NCT07746271Phase 3Not Yet RecruitingPrimary

Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial

NCT06773299Not ApplicableActive Not RecruitingPrimary

Enhancing Intergenerational Health in Nigeria: Peripartum as Critical Life Stage for Cardiovascular Health

NCT04298034Phase 3Active Not Recruiting

Preeclampsia Postpartum Antihypertensive Treatment

NCT05852054Phase 3Completed

Supporting Transitions to Primary Care Among Under-resourced, Postpartum Women (STEP-UP)

NCT06835959Not ApplicableRecruitingPrimary

Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy

NCT06523569Not ApplicableActive Not RecruitingPrimary

Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy

NCT06466161Not ApplicableRecruitingPrimary

Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients

NCT07356518Not ApplicableRecruiting

Telehealth and Remote Blood Pressure

NCT06105775Not ApplicableRecruitingPrimary

Inorganic Nitrate Supplementation in Chronic Hypertensive Pregnancies

NCT06785116Phase 4Recruiting

A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)

NCT05473767Not ApplicableCompleted

Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children

NCT07298759Not ApplicableActive Not RecruitingPrimary

The Effect of Hydroxytyrosol Administration on Superoxide Dismutase, Pulsatility Index and Resistance Index of Uterine Artery Doppler and Flow-Mediated Dilatation of Brachial Artery In Mothers With Hypertension In Pregnancy

NCT07074548Not ApplicableCompletedPrimary

Effect of Hydroxytyrosol on NLR, MLR, and SOD in Hypertensive Pregnant Women

NCT03944512Phase 3Terminated

Pravastatin to Prevent Preeclampsia

NCT05049616Phase 4CompletedPrimary

Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension

NCT07023003Phase 4RecruitingPrimary

Postpartum Evaluation of Nifedipine and Enalapril for Hypertension

NCT04626245Not ApplicableActive Not RecruitingPrimary

Mindfulness & Mechanisms Study

NCT06054841Not ApplicableCompletedPrimary

Reshaping Postpartum Follow-up

NCT06842875Not ApplicableRecruitingPrimary

Rhode Island - Statewide Postpartum Hypertension Remote Surveillance

Scroll to load more

Research Network

Activity Timeline